Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Stimulated CD4+ T lymphocytes can differentiate into effector T cell (Teff) or inducible regulatory T cell (Treg) subsets with specific immunological roles. We show that Teff and Treg require distinct metabolic programs to support these functions. Th1, Th2, and Th17 cells expressed high surface levels of the glucose transporter Glut1 and were highly glycolytic. Treg, in contrast, expressed low levels of Glut1 and had high lipid oxidation rates. Consistent with glycolysis and lipid oxidation promoting Teff and Treg, respectively, Teff were selectively increased in Glut1 transgenic mice and reliant on glucose metabolism, whereas Treg had activated AMP-activated protein kinase and were dependent on lipid oxidation. Importantly, AMP-activated protein kinase stimulation was sufficient to decrease Glut1 and increase Treg generation in an asthma model. These data demonstrate that CD4+ T cell subsets require distinct metabolic programs that can be manipulated in vivo to control Treg and Teff development in inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In contrast to Treg cells, TH2 cells were shown to display an increased glycolytic rate44.”
From Selective degradation of PU.1 during autophagy represses the differentiation and antitumour activity of TH9 cells (2017) · cites this paper as [44]
The cited source says what the claim attributes to it.
In the citing paper
“This increased mitochondrial metabolism in Tregs was found to be due to increased AMPK-dependent fatty acid oxidation (MacIver et al., 2011; Michalek et al., 2011).”
From Mitochondria in the Regulation of Innate and Adaptive Immunity (2015) · cites this paper as Michalek et al., 2011
The cited source says what the claim attributes to it.
In the citing paper
“Different subsets of T cells, as well as different stages following T cell activation, are characterized by the use of different metabolic pathways [97, 108, 109].”
From Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function (2013) · cites this paper as [108]
In the citing paper
“Tregs have elevated levels of oxidative phosphorylation and decreased glycolytic flux compared to Th17 cells (Michalek et al., 2011).”
From Mitochondria in the Regulation of Innate and Adaptive Immunity (2015) · cites this paper as Michalek et al., 2011
In the citing paper
“This was first demonstrated by Michalek et al. (34), who determined that proinflammatory CD4+ T helper (TH) cells (TH1, TH2, and TH17 lineages) displayed a strong bias toward glycolysis over mitochondrial metabolism, whereas induced CD4+ T regulatory (Treg) lineage cells displayed a mixed metabolism involving glycolysis, lipid oxidation, and OXPHOS.”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088 · cited 1×
“To meet these requirements, activated T cells decrease lipid oxidation and undergo a rapid increase in glycolysis (4).”
BackgroundmTOR regulates memory CD8 T-cell differentiation
Araki, K., Turner, A. P., Shaffer, V. O., Gangappa, S., Keller, S. A., Bachmann, M. F., Larsen, C. P., & Ahmed, R. (2009) · Nature · doi:10.1038/nature08155 · Cited by 1,575 · cited 2×
“At the conclusion of an immune response, decreased glycolysis and increased lipid oxidation can favor the enrichment of long-lived CD8 memory cells (5, 6).”
BackgroundEnhancing CD8 T-cell memory by modulating fatty acid metabolism
Pearce, E. L., Walsh, M. C., Cejas, P. J., Harms, G. M., Shen, H., Wang, L.-S., Jones, R. G., & Choi, Y. (2009) · Nature · doi:10.1038/nature08097 · Cited by 1,559 · cited 4×
“Glucose uptake, glycolysis, and lipid oxidation were measured as previously described (5, 7, 13).”
BackgroundMethodInfluentialThe mTOR Kinase Differentially Regulates Effector and Regulatory T Cell Lineage Commitment
Delgoffe, G. M., Kole, T. P., Zheng, Y., Zarek, P. E., Matthews, K. L., Xiao, B., Worley, P. F., Kozma, S. C., & Powell, J. D. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.014 · Cited by 1,284
Jacobs, S. R., Herman, C. E., MacIver, N. J., Wofford, J. A., Wieman, H. L., Hammen, J. J., & Rathmell, J. C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4476 · Cited by 850 · cited 5×
“1G) and Ig deposition in the kidneys (3).”
BackgroundSelf-citationAMP-Activated Protein Kinase – Development of the Energy Sensor Concept
Hardie, D. G., Hawley, S. A., & Scott, J. W. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.108944 · Cited by 813 · cited 1×
“In contrast, the AMPK pathway acts to inhibit mTOR by suppressing mTOR signaling and to promote mitochondrial oxidative metabolism rather than glycolysis (10).”
BackgroundThe AKT–mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells
Haxhinasto, S., Mathis, D., & Benoist, C. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071477 · Cited by 737 · cited 1×
“Inhibition of mTOR can result in the elevated oxidation of exogenous FA (15) and promote Treg differentiation (16).”
BackgroundStability of the Regulatory T Cell Lineage in Vivo
Rubtsov, Y. P., Niec, R. E., Josefowicz, S., Li, L., Darce, J., Mathis, D., Benoist, C., & Rudensky, A. Y. (2010) · Science · doi:10.1126/science.1191996 · Cited by 730 · cited 1×
“stable pool of important immune regulatory cells (18), and lipid oxidation may be central in contributing to their maintenance and self-renewal.”
BackgroundWieman, H. L., Wofford, J. A., & Rathmell, J. C. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-07-0593 · Cited by 593 · cited 3×
“Glucose uptake, glycolysis, and lipid oxidation were measured as previously described (5, 7, 13).”
BackgroundMethodSelf-citation
Cited by
Items 301–400 of 1,005
Immune Response Regulation in the Tumor Microenvironment by Hypoxia
Labiano, S., Palazón, A., & Melero, I. (2015) · Seminars in Oncology · doi:10.1053/j.seminoncol.2015.02.009 · Cited by 169
The role of HIF in immunity and inflammation
Cummins, E. P., Keogh, C. E., Crean, D., & Taylor, C. T. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2015.12.004 · Cited by 150
“Treg cells use lipid oxidation and oxidative phosphorylation to a greater extent than pro-inflammatory Th cells, which have a greater reliance on glycolysis (Michalek et al., 2011; Shi et al., 2011).”
BackgroundAl-Khami, A. A., Hossain, F., Wyczechowska, D., Hernandez, C., Zheng, L., Reiss, K., Del Valle, L., Trillo-Tinoco, J., Maj, T., Zou, W., et al. (2015) · Journal for ImmunoTherapy of Cancer · doi:10.1186/2051-1426-3-s2-o18 · Cited by 150
Kunisada, Y., Eikawa, S., Tomonobu, N., Domae, S., Uehara, T., Hori, S., Furusawa, Y., Hase, K., Sasaki, A., & Udono, H. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.10.009 · Cited by 149
“Regarding the energy metabolism, Treg generation is fueled by fatty acid oxidation, followed by oxidative phosphorylation in mitochondria (Michalek et al., 2011; Gerriets et al., 2015).”
BackgroundB1a B cells require autophagy for metabolic homeostasis and self-renewal
Clarke, A. J., Riffelmacher, T., Braas, D., Cornall, R. J., & Simon, A. K. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20170771 · Cited by 148
T Cell Metabolism in Infection
Wik, J. A., & Skålhegg, B. S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.840610 · Cited by 170
Lachmandas, E., Bompadre, M. B., Cheng, S., Kumar, V., van Laarhoven, A., Wang, X., Ammerdorffer, A., Boutens, L., de Jong, D., Kanneganti, T., et al. (2016) · European Journal of Immunology · doi:10.1002/eji.201546259 · Cited by 157
Ancillary Activity: Beyond Core Metabolism in Immune Cells
Puleston, D. J., Villa, M., & Pearce, E. L. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.06.019 · Cited by 148
“During Th17 differentiation, T cells will polarize toward Tregs if glycolysis is inhibited, but inhibiting FAO blocks Treg induction and favors Th17 cells (Michalek et al., 2011; Shi et al., 2011).”
BackgroundRole of Macrophages in Wound Healing
Willenborg, S., Injarabian, L., & Eming, S. A. (2022) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041216 · Cited by 178
Gerriets, V. A., Danzaki, K., Kishton, R. J., Eisner, W., Nichols, A. G., Saucillo, D. C., Shinohara, M. L., & MacIver, N. J. (2016) · European Journal of Immunology · doi:10.1002/eji.201545861 · Cited by 146
Self-citationGlycolysis inhibition as a cancer treatment and its role in an anti-tumour immune response
Gill, K. S., Fernandes, P., O’Donovan, T. R., McKenna, S. L., Doddakula, K., Power, D. G., Soden, D. M., & Forde, P. F. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.06.005 · Cited by 165
Fatty acid metabolism in CD 8 + T cell memory: Challenging current concepts
Raud, B., McGuire, P. J., Jones, R. G., Sparwasser, T. D., & Berod, L. (2018) · Immunological Reviews · doi:10.1111/imr.12655 · Cited by 173
Immunometabolism at the intersection of metabolic signaling, cell fate, and systems immunology
Chi, H. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-022-00840-x · Cited by 157
Sun, I.-H., Oh, M.-H., Zhao, L., Patel, C. H., Arwood, M. L., Xu, W., Tam, A. J., Blosser, R. L., Wen, J., & Powell, J. D. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701477 · Cited by 145
“As previously shown, Tregs preferentially use fatty acid oxidation as a major source of energy production compared with effector CD4 T cells (45).”
BackgroundKlotz, L., Eschborn, M., Lindner, M., Liebmann, M., Herold, M., Janoschka, C., Torres Garrido, B., Schulte-Mecklenbeck, A., Gross, C. C., Breuer, J., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aao5563 · Cited by 145
Hu, B., Lin, J., Yang, X., & Sang, X. (2020) · Cell Proliferation · doi:10.1111/cpr.12772 · Cited by 164
Metabolic modulation of immune checkpoints and novel therapeutic strategies in cancer
Wang, Y., Wang, Y., Ren, Y., Zhang, Q., Yi, P., & Cheng, C. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.02.010 · Cited by 153
Functional reprogramming of regulatory T cells in the absence of Foxp3
Charbonnier, L.-M., Cui, Y., Stephen-Victor, E., Harb, H., Lopez, D., Bleesing, J. J., Garcia-Lloret, M. I., Chen, K., Ozen, A., Carmeliet, P., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0442-x · Cited by 145
Role of T Cells in Malnutrition and Obesity
Gerriets, V. A., & MacIver, N. J. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00379 · Cited by 145
“IL-17 expression has also been found to be high in obese human beings (41), and peripheral blood samples from human beings with type 2 diabetes mellitus have increased numbers of circulating Th17 cells (42, 43).”
BackgroundInfluentialSelf-citationThe PI3K pathway in B cell metabolism
Jellusova, J., & Rickert, R. C. (2016) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2016.1215288 · Cited by 162
“Thus, similarly to hepatocytes, ERRa regulates metabolism in T lymphocytes as well (Michalek et al., 2011b).”
BackgroundInfluentialThe immunologic Warburg effect: Evidence and therapeutic opportunities in autoimmunity
Kornberg, M. D. (2020) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1486 · Cited by 163
“Preventing glycolytic upregulation via glucose deprivation, GLUT1 or HIF-1α deficiency, or 2-DG shifts the balance between these subsets, preventing TH1/TH17 differentiation and reciprocally favoring Treg development both in vitro and in vivo (Michalek et al., 2011; Shi et al., 2011).”
BackgroundFatty acid oxidation is dispensable for human macrophage IL-4-induced polarization
Namgaladze, D., & Brüne, B. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.06.007 · Cited by 157
Mitochondrial dynamics controls anti-tumour innate immunity by regulating CHIP-IRF1 axis stability
Gao, Z., Li, Y., Wang, F., Huang, T., Fan, K., Zhang, Y., Zhong, J., Cao, Q., Chao, T., Jia, J., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01919-0 · Cited by 143
Fueling the flame: bioenergy couples metabolism and inflammation
Liu, T. F., Brown, C. M., Gazzar, M. E., McPhail, L. C., Millet, P., Rao, A., Vachharajani, V., Yoza, B. K., & McCall, C. E. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0212078 · Cited by 155
Exercise immunology: Future directions
Nieman, D. C., & Pence, B. D. (2020) · Journal of Sport and Health Science · doi:10.1016/j.jshs.2019.12.003 · Cited by 140
“Cellular activation in the immune system is almost universally supported by an enhanced program of glycolysis, with glucose metabolism underlying proinflammatory responses in macrophages and dendritic cells(7,8) and Nucleotide-binding oligomerization domain, Leucine rich Repeat and Pyrin domain containing (NLRP3) infl…”
BackgroundFundamentals of T Cell Metabolism and Strategies to Enhance Cancer Immunotherapy
Rangel Rivera, G. O., Knochelmann, H. M., Dwyer, C. J., Smith, A. S., Wyatt, M. M., Rivera-Reyes, A. M., Thaxton, J. E., & Paulos, C. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.645242 · Cited by 140
Sormendi, S., & Wielockx, B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00040 · Cited by 141
“Contrary to Teff, Treg cells rely on both FAO and OxPhos for ATP upon activation (127, 129, 130).”
BackgroundMetabolic conditioning of CD8+ effector T cells for adoptive cell therapy
Geltink, R. I. K., Edwards-Hicks, J., Apostolova, P., O’Sullivan, D., Sanin, D. E., Patterson, A. E., Puleston, D. J., Ligthart, N. A. M., Buescher, J. M., Grzes, K. M., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0256-z · Cited by 152
Exhaustion of T lymphocytes in the tumor microenvironment: Significance and effective mechanisms
Gholami, M. D., Kardar, G. A., Saeedi, Y., Heidari, S., Garssen, J., & Falak, R. (2017) · Cellular Immunology · doi:10.1016/j.cellimm.2017.10.002 · Cited by 161
“As a consequence, T cells not only are unable to develop tumoricidal effects, but also alter their differentiation program resulting in the generation of cell types that develop due to limited glucose supplies, such as Tregs and exhausted T lymphocytes [174,176].”
Kouidhi, S., Elgaaied, A. B., & Chouaib, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00270 · Cited by 138
“Treg favor FA catabolism via b-oxidation and prioritize oxidative ATP to meet their energetic demands, an important metabolic phenotype for the differentiation of Treg (38).”
BackgroundLactate: a multifunctional signaling molecule
Lee, T.-Y. (2021) · Journal of Yeungnam Medical Science · doi:10.12701/yujm.2020.00892 · Cited by 156
The Complex Integration of T-cell Metabolism and Immunotherapy
Madden, M. Z., & Rathmell, J. C. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0569 · Cited by 156
“Importantly, as T cells activate and are guided by inflammatory and cytokine cues to gain distinct sets of effector functions, they also develop and require specific metabolic programs[24].”
BackgroundSelf-citationUnderstanding the Central Role of Citrate in the Metabolism of Cancer Cells and Tumors: An Update
Icard, P., Coquerel, A., Wu, Z., Gligorov, J., Fuks, D., Fournel, L., Lincet, H., & Simula, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126587 · Cited by 152
The extracellular matrix integrates mitochondrial homeostasis
Zhang, H., Tsui, C. K., Garcia, G., Joe, L. K., Wu, H., Maruichi, A., Fan, W., Pandovski, S., Yoon, P. H., Webster, B. M., et al. (2024) · Cell · doi:10.1016/j.cell.2024.05.057 · Cited by 155
T cell dysfunction and therapeutic intervention in cancer
Zebley, C. C., Zehn, D., Gottschalk, S. M., & Chi, H. (2024) · Nature Immunology · doi:10.1038/s41590-024-01896-9 · Cited by 159
Biochemical Underpinnings of Immune Cell Metabolic Phenotypes
Olenchock, B. A., Rathmell, J. C., & Vander Heiden, M. G. (2017) · Immunity · doi:10.1016/j.immuni.2017.04.013 · Cited by 137
“Where studied, each T cell subset has been found to display a unique metabolic program that supports the biochemical requirements of their distinct cellular functions (Beier et al., 2015; Gerriets et al., 2015; Michalek et al., 2011; Oestreich et al., 2014; Shi et al., 2011).”
Self-citationTargeting mitochondria in cancer: current concepts and immunotherapy approaches
Pustylnikov, S., Costabile, F., Beghi, S., & Facciabene, A. (2018) · Translational research · doi:10.1016/j.trsl.2018.07.013 · Cited by 145
“Fatty acid metabolism is similarly vital for Tm functions and T regulatory differentiation.(59) IL-15, a cytokine that promotes CD8+ Tm cell development and maintenance, promotes mitochondrial biogenesis and the expression of CPT1a.”
Metabolic Reprogramming and Reactive Oxygen Species in T Cell Immunity
Peng, H., Lucavs, J., Ballard, D. J., Das, J. K., Kumar, A., Wang, L., Ren, Y., Xiong, X., & Song, J. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.652687 · Cited by 156
Cancer metabolism and tumor microenvironment: fostering each other?
Yuan, Y., Li, H., Wang, P., Chen, L., Guo, D. S., Jiang, H., He, B., Qin, S., Wang, K., Li, N., et al. (2021) · Science China Life Sciences · doi:10.1007/s11427-021-1999-2 · Cited by 144
“AMPK stimulation was sufficient to increase Treg generation in an asthma model (Michalek et al., 2011).”
Effector T cells require fatty acid metabolism during murine graft-versus-host disease
Byersdorfer, C. A., Tkachev, V., Opipari, A. W., Goodell, S., Swanson, J., Sandquist, S., Glick, G. D., & Ferrara, J. L. M. (2013) · Blood · doi:10.1182/blood-2013-04-495515 · Cited by 135
What Defines NK Cell Functional Fate: Phenotype or Metabolism?
Poznanski, S. M., & Ashkar, A. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01414 · Cited by 158
Hossain, M. A., Liu, G., Dai, B., Si, Y., Yang, Q., Wazir, J., Birnbaumer, L., & Yang, Y. (2020) · Medicinal Research Reviews · doi:10.1002/med.21727 · Cited by 154
Immune Cells and Inflammation in Diabetic Nephropathy
Zheng, Z., & Zheng, F. (2016) · Journal of Diabetes Research · doi:10.1155/2016/1841690 · Cited by 134
“Th17 has high levels of HIF-1α and deletion of HIF-1α in T cells inhibits Th17 differentiation in vitro and in experimental autoimmune encephalomyelitis [103].”
BackgroundSun, Y., Tian, T., Gao, J., Liu, X., Hou, H., Cao, R., Li, B., Quan, M., & Guo, L. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.01.014 · Cited by 331
“Furthermore, AMPK activation increased the percentage of airway-infiltrating Treg cells in a mouse model of asthma (Michalek et al., 2011).”
BackgroundInfluentialMendoza, M. S., & Morales‐Montor, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00348 · Cited by 149
“Interestingly, the proliferation and generation of active T cells are governed by different metabolic glycolytic demands (142).”
BackgroundTargeting T cell metabolism in the tumor microenvironment: an anti‐cancer therapeutic strategy
Yin, Z., Bai, L., Li, W., Zeng, T., Tian, H., & Cui, J. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1409-3 · Cited by 133
Hypoxia Dictates Metabolic Rewiring of Tumors: Implications for Chemoresistance
Belisario, D. C., Kopecka, J., Pasino, M., Akman, M., De Smaele, E., Donadelli, M., & Riganti, C. (2020) · Cells · doi:10.3390/cells9122598 · Cited by 133
“Activated T-cells highly rely on anaerobic glycolysis, as suggested by the upregulation of GLUT1 during T-lymphocyte activation [94].”
BackgroundSirtuin deacylases: a molecular link between metabolism and immunity
Preyat, N., & Léo, O. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.1112557 · Cited by 143
Araki, K., Ellebedy, A. H., & Ahmed, R. (2011) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2011.08.006 · Cited by 132
“recently demonstrated that at least in vitro the levels of the glucose transporter (Glut1) and that of glycolysis are higher in effector CD4 T cells in comparison to Tregs [27].”
Freemerman, A. J., Zhao, L., Pingili, A. K., Teng, B., Cozzo, A. J., Fuller, A. M., Johnson, A. R., Milner, J. J., Lim, M. F., Galanko, J. A., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1800002 · Cited by 132
“Substrate metabolism regulates MF phenotype (6, 11, 12, 19, 54, 55),”
BackgroundSelf-citationThe role of low-level lactate production in airway inflammation in asthma
Ostroukhova, M., Goplen, N., Karim, M. Z., Michalec, L., Guo, L., Liang, Q., & Alam, R. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00221.2011 · Cited by 131
Metabolic communication in tumors: a new layer of immunoregulation for immune evasion
Ho, P.-C., & Liu, P.-S. (2016) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-016-0109-1 · Cited by 124
“formation in both in vitro and in vitro assays [19, 20].”
BackgroundThe essential functions of mitochondrial dynamics in immune cells
Xie, J.-H., Li, Y., & Jin, J. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0480-1 · Cited by 142
Synchronizing transcriptional control of T cell metabolism and function
Man, K., & Kallies, A. (2015) · Nature reviews. Immunology · doi:10.1038/nri3874 · Cited by 141
Metabolism as a Target for Modulation in Autoimmune Diseases
Huang, N., & Perl, A. (2018) · Trends in Immunology · doi:10.1016/j.it.2018.04.006 · Cited by 137
Kunisawa, J., Sugiura, Y., Wake, T., Nagatake, T., Suzuki, H., Nagasawa, R., Shikata, S., Honda, K., Hashimoto, E., Suzuki, Y., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.08.063 · Cited by 137
Schirrmacher, V. (2020) · Biomedicines · doi:10.3390/biomedicines8110526 · Cited by 124
“The signaling protein TRAF6 plays a key role for CD8+ T cells to switch from glycolytic to oxidative metabolism [102].”
BackgroundFatty acid metabolism of immune cells: a new target of tumour immunotherapy
Zhang, S., Lv, K., Liu, Z., Zhao, R., & Li, F. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01807-9 · Cited by 153
“Treg cells increase their glycolysis rate and lipid biosynthesis, and fatty acid oxidation helps to amplify their metabolic signals [71, 72].”
BackgroundAutophagy and inflammatory diseases
Jones, S. A., Mills, K. H. G., & Harris, J. (2013) · Immunology and Cell Biology · doi:10.1038/icb.2012.82 · Cited by 136
Glucose Metabolism in T Cells and Monocytes: New Perspectives in HIV Pathogenesis
Palmer, C. S., Cherry, C. L., Sada‐Ovalle, I., Singh, A., & Crowe, S. M. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.02.012 · Cited by 142
“In contrast, the proinflammatory Th17 cells, together with Th1 and Th2 cells express high surface levels of Glut1 and are highly glycolytic (MacIver et al., 2013; Palmer et al., 2015b; Michalek et al., 2011).”
BackgroundBöttcher, M., Renner, K., Berger, R., Mentz, K., Thomas, S., Cardenas-Conejo, Z. E., Dettmer, K., Oefner, P. J., Mackensen, A., Kreutz, M., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1445454 · Cited by 124
Immune cell metabolism and metabolic reprogramming
Hu, C., Xuan, Y., Zhang, X., Liu, Y., Yang, S., & Yang, K. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07474-2 · Cited by 147
The AMP analog AICAR modulates the T reg /T h 17 axis through enhancement of fatty acid oxidation
Gualdoni, G. A., Mayer, K. A., Göschl, L., Boucheron, N., Ellmeier, W., & Zlabinger, G. J. (2016) · The FASEB Journal · doi:10.1096/fj.201600522r · Cited by 123
Metabolic Switch in the Tumor Microenvironment Determines Immune Responses to Anti-cancer Therapy
Wegiel, B., Vuerich, M., Daneshmandi, S., & Seth, P. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00284 · Cited by 133
“AMPK regulates generation of CD8 memory T cells, promotion of T regulatory cells, and suppression of T effector function (50, 53).”
BackgroundCancer Metabolism Drives a Stromal Regenerative Response
Schwörer, S., Vardhana, S. A., & Thompson, C. B. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.01.015 · Cited by 123
“…2008), depletion of available glucose favors the growth and differentiation of regulatory T-cells, which feature higher AMPK activity, decreased glucose oxidation, and increased fatty acid oxidation to support energy homeostasis (Angelin et al., 2017; Gualdoni et al., 2016; Michalek et al., 2011).”
BackgroundDietary Regulation of Immunity
Lee, A. H., & Dixit, V. D. (2020) · Immunity · doi:10.1016/j.immuni.2020.08.013 · Cited by 123
“In addition, the differentiation of naive T cells (CD4 and CD8) into an effector state upon antigen recognition is dependent on glucose and glutamine (Jacobs et al., 2008; Michalek et al., 2011; Pearce et al., 2009; Wang et al., 2011).”
BackgroundMatias, M. I., Yong, C. S. M., Foroushani, A. B. K., Goldsmith, C., Mongellaz, C., Sezgin, E., Levental, K. R., Talebi, A., Perrault, J., Riviere, A., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109911 · Cited by 132
Making sense of regulatory T cell suppressive function
Shalev, I., Schmelzle, M., Robson, S. C., & Levy, G. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.04.003 · Cited by 121
“Treg cells are anergic and have been recently shown to express low levels of the glucose transporter Glut1 and to have high rates of lipid oxidation in contrast to effector cells that are highly glycolytic [99].”
BackgroundAutophagy in T‐cell development, activation and differentiation
Bronietzki, A. W., Schuster, M., & Schmitz, I. (2015) · Immunology & Cell Biology · doi:10.1038/icb.2014.81 · Cited by 121
Distinct metabolic programs in activated T cells: opportunities for selective immunomodulation
Wahl, D. R., Byersdorfer, C. A., Ferrara, J. L. M., Opipari, A. W., & Glick, G. D. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01148.x · Cited by 132
“While inhibiting glycolysis is a promising immunomodulatory strategy and likely spares FAO-dependent Treg and memory CD8+ cells, there are several concerns about undesired side effects.”
BackgroundInfluentialThe Emerging Facets of Non-Cancerous Warburg Effect
Abdel‐Haleem, A. M., Lewis, N. E., Jamshidi, N., Mineta, K., Gao, X., & Gojobori, T. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00279 · Cited by 131
Microenvironmental influences on T cell immunity in cancer and inflammation
Heintzman, D. R., Fisher, E. L., & Rathmell, J. C. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00833-2 · Cited by 131
“It has been established that Th17 cells can utilize glycolysis at a much higher rate than other T cell subsets[54, 55] and seem to be especially sensitive to temperature change [51, 55].”
BackgroundSelf-citationCellular metabolism of myeloid cells in sepsis
Arts, R. J. W., Gresnigt, M. S., Joosten, L. A. B., & Netea, M. G. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.4mr0216-066r · Cited by 121
“OxPhos through exogenously derived fatty acids [9].”
Niche-Selective Inhibition of Pathogenic Th17 Cells by Targeting Metabolic Redundancy
Wu, L., Hollinshead, K. E. R., Hao, Y., Au, C., Kroehling, L., Ng, C., Lin, W.-Y., Li, D., Silva, H. M., Shin, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.014 · Cited by 121
The Role of the PI3K Signaling Pathway in CD4+ T Cell Differentiation and Function
Han, J. M., Patterson, S. J., & Levings, M. K. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00245 · Cited by 118
Enhanced oxidative phosphorylation in NKT cells is essential for their survival and function
Kumar, A., Pyaram, K., Yarosz, E. L., Hong, H. S., Lyssiotis, C. A., Giri, S., & Chang, C. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901376116 · Cited by 129
“T cell activation and their subsequent phenotypic adaptation into different effector states are characterized by distinct metabolic pathways (25, 26).”
BackgroundRecruitment and Expansion of Tregs Cells in the Tumor Environment—How to Target Them?
Cinier, J., Hubert, M., Besson, L., Roio, A. D., Rodriguez, C., Lombardi, V., Caux, C., & Ménétrier‐Caux, C. (2021) · Cancers · doi:10.3390/cancers13081850 · Cited by 136
“CD36 finetunes the mitochondrial fitness and NAD levels to program Treg adaptation to a lactic acid-enriched TME [228] and favors Treg survival dependent on lipid oxidation [223,229,230].”
BackgroundThinking outside the box: non-canonical targets in multiple sclerosis
Bierhansl, L., Hartung, H.-P., Aktas, O., Ruck, T., Roden, M., & Meuth, S. G. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00477-5 · Cited by 117
Targeting T cell metabolism to regulate T cell activation, differentiation and function in disease
Patel, C. H., & Powell, J. D. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.04.006 · Cited by 116
“Likewise, for CD4 T cells, it has been shown that differentiation in to distinct effector subsets is accompanied by differential metabolic programming [4].”
BackgroundRebalancing Immune Homeostasis to Treat Autoimmune Diseases
Horwitz, D. A., Fahmy, T. M., Piccirillo, C. A., & Cava, A. L. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.08.003 · Cited by 135
Molecular control of pathogenic Th17 cells in autoimmune diseases
Wu, B., & Wan, Y. Y. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106187 · Cited by 136
Role of Metabolism in the Immunobiology of Regulatory T Cells
Galgani, M., De Rosa, V., La Cava, A., & Matarese, G. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600242 · Cited by 116
Almeida, L., Dhillon-LaBrooy, A., Carriche, G. M., Berod, L., & Sparwasser, T. D. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.03.033 · Cited by 123
The role of ROS in tumor infiltrating immune cells and cancer immunotherapy
Shah, R., Ibis, B., Kashyap, M., & Boussiotis, V. A. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155747 · Cited by 130
Modulation of T Cell Metabolism and Function through Calcium Signaling
Fracchia, K. M., Pai, C., & Walsh, C. M. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00324 · Cited by 135
Allison, K. E., Coomber, B. L., & Bridle, B. W. (2017) · Immunology · doi:10.1111/imm.12777 · Cited by 109
mTOR and metabolic pathways in T cell quiescence and functional activation
Yang, K., & Chi, H. (2012) · Seminars in Immunology · doi:10.1016/j.smim.2012.12.004 · Cited by 130
AMPKα1 deficiency amplifies proinflammatory myeloid APC activity and CD40 signaling
Carroll, K. C., Viollet, B., & Suttles, J. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0313157 · Cited by 114
Pompura, S. L., Wagner, A., Kitz, A., Laperche, J. M., Yosef, N., Dominguez‐Villar, M., & Hafler, D. A. (2021) · Journal of Clinical Investigation · doi:10.1172/jci138519 · Cited by 127
Torigoe, M., Iwata, S., Nakayamada, S., Sakata, K., Zhang, M., Hajime, M., Miyazaki, Y., Narisawa, M., Ishii, K., Shibata, H., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601908 · Cited by 121
Zhao, H., Dennery, P. A., & Yao, H. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00521.2017 · Cited by 128
Luccia, B. D., Gilfillan, S., Cella, M., Colonna, M., & Huang, S. C. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20180549 · Cited by 122
“Th17s rely on the mTORC1-HIF1α pathway, which promotes glycolysis and directly induces RORγt expression (Delgoffe et al., 2009, 2011; Dang et al., 2011; Michalek et al., 2011; Shi et al., 2011; Kurebayashi et al., 2012; Gerriets et al., 2015).”
Current Understanding of Hypoxia in Glioblastoma Multiforme and Its Response to Immunotherapy
Park, J. H., & Lee, H. K. (2022) · Cancers · doi:10.3390/cancers14051176 · Cited by 137
Elevated transferrin receptor impairs T cell metabolism and function in systemic lupus erythematosus
Voss, K., Sewell, A. E., Krystofiak, E., Gibson-Corley, K. N., Young, A., Basham, J. H., Sugiura, A., Arner, E. N., Beavers, W. N., Kunkle, D. E., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.abq0178 · Cited by 125
Self-citationCancer cell metabolic reprogramming: a keystone for the response to immunotherapy
Cerezo, M., & Rocchi, S. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03175-5 · Cited by 125
Liu, Z., Liu, W., Wang, W., Ma, Y., Wang, Y., Drum, D. L., Cai, J., Blevins, H., Lee, E., Shah, S., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2302878120 · Cited by 130
“…also been implicated in regulation regulatory T cells or myeloid - derived suppressive cells that are known for their T cell inhibitory activity (56, 57), the pharmacological approaches targeting FAO strategically may be exploited to broaden the impact of cancer immunotherapies including CAR T…”
Kim, D. S., Kwon, J.-E., Lee, S. H., Kim, E. K., Ryu, J.-G., Jung, K.-A., Choi, J.-W., Park, M.-J., Moon, Y.-M., Park, S.-H., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01525 · Cited by 110
“Treatment of CD4+ T cells with etomoxir, a specific inhibitor of CPTI, reduces the Treg population (30).”
BackgroundInterleukin-2 and regulatory T cells in rheumatic diseases
Kolios, A. G. A., Tsokos, G. C., & Klatzmann, D. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-021-00707-x · Cited by 127
The Insulin Receptor Plays a Critical Role in T Cell Function and Adaptive Immunity
Fischer, H. J., Sie, C., Schumann, E., Witte, A.-K., Dressel, R., van den Brandt, J., & Reichardt, H. M. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601011 · Cited by 109
“The importance of these changes was demonstrated by overexpressing Glut1 in mice, which led to increased proliferation and cytokine production by effector T cells (12, 14).”
BackgroundLiu, Q., Zhu, F., Liu, X., Lu, Y., Yao, K., Tian, N., Tong, L., Figge, D. A., Wang, X., Han, Y., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00575-z · Cited by 129
Metadata
- Authors
- Michalek, R. D., Gerriets, V. A., Jacobs, S. R., Macintyre, A. N., MacIver, N. J., Mason, E. F., Sullivan, S. A., Nichols, A. G., & Rathmell, J. C.
- Affiliations
- Duke University (US)
- Duke Medical Center (US)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-03
- Volume
- 186
- Issue
- 6
- Pages
- 3299-3303
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC3198034
- OpenAlex
- W2157739158
- Cited by
- 2,091
- References
- 18
- Citations by year
- 2026: 116 · 2025: 133 · 2024: 168 · 2023: 163 · 2022: 214 · 2021: 215 · 2020: 209 · 2019: 167 · 2018: 147 · 2017: 164 · 2016: 122 · 2015: 88 · 2014: 69 · 2013: 55 · 2012: 47
- FWCI
- 25.83
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DukeSpace (Duke University) (submittedVersion, cc-by-nc-nd)
- Funders
- Cancer Research Institute
- Lupus Research Institute
- Leukemia and Lymphoma Society
- American Asthma Foundation
- Lupus Research Alliance
- National Institutes of Health
- University of California, San Francisco
- National Heart, Lung, and Blood Institute (R01HL108006)
- National Institute of Allergy and Infectious Diseases (R01AI063345)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- effector T cells, regulatory T cells, glycolysis, lipid oxidation, glucose transporter 1, AMPK, Th1 cells, Th2 cells, Th17 cells, asthma, Treg generation, inflammatory diseases
- MeSH terms
- Animals, Asthma, Cell Survival, Cells, Cultured, Disease Models, Animal, Glycolysis, T-Lymphocytes, Helper-Inducer, Mice, Inbred C57BL, Mice, Transgenic, Lipid Peroxidation, Immunophenotyping, T-Lymphocyte Subsets, T-Lymphocytes, Regulatory, Glucose Transporter Type 1, Mice, AMP-Activated Protein Kinases, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.